Cargando…

Pseudohyperphosphatemia in a patient with relapsed multiple myeloma after bone marrow transplantation: A case report

Pseudohyperphosphatemia is a laboratory artifact characterized by falsely elevated serum phosphate mostly due to paraprotein interference on the conventional automated analyzer. Clinician recognition of this phenomenon and pre‐analytical preparation, including dilution or protein precipitation, can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kritmetapak, Kittrawee, Dumrongsukit, Sophon, Jinchai, Jittirat, Wongprommek, Panibud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637355/ https://www.ncbi.nlm.nih.gov/pubmed/31360504 http://dx.doi.org/10.1002/ccr3.2264

Ejemplares similares

Pseudohyperphosphatemia in a Patient with Multiple Myeloma
por: Lee, Yonggu, et al.
Publicado: (2007)

Pseudohyperphosphatemia in Waldenstrom's Macroglobulinemia
por: Amalnath, S. D., et al.
Publicado: (2013)

Pseudohyperphosphatemia due to contamination with heparin: A case for caution
por: Senthilkumaran, S., et al.
Publicado: (2014)

Parathyroid Hormone Measurement in Chronic Kidney Disease: From Basics to Clinical Implications
por: Kritmetapak, Kittrawee, et al.
Publicado: (2019)

Bile cast nephropathy in a patient with cholangiocarcinoma – a case report
por: Kritmetapak, Kittrawee, et al.
Publicado: (2018)

Incidence of and risk factors for post-parathyroidectomy hungry bone syndrome in patients with secondary hyperparathyroidism
por: Kritmetapak, Kittrawee, et al.
Publicado: (2020)

Extramedullary Gastric Relapse at the Time of Bone Marrow Relapse of Acute Lymphoblastic Leukemia after Allogeneic Bone Marrow Transplantation
por: Ikeuchi, Kazuhiko, et al.
Publicado: (2017)

Clinical and pathological characteristics of non-diabetic renal disease in type 2 diabetes patients
por: Kritmetapak, Kittrawee, et al.
Publicado: (2018)

Elevated Serum Uric Acid is Associated with Rapid Decline in Kidney Function: A 10-Year Follow-Up Study
por: Kritmetapak, Kittrawee, et al.
Publicado: (2020)

The Impact of New-Onset Diabetes Mellitus and Hypertension on All-Cause Mortality in an Apparently Healthy Population: A Ten-Year Follow-Up Study
por: Charoensri, Suranut, et al.
Publicado: (2021)

Cryptococcal Meningoencephalitis 10 Years After Bone Marrow Transplant in a Patient With Multiple Myeloma
por: Stepman, Gauthier, et al.
Publicado: (2020)

Factors influencing extramedullary relapse after allogeneic transplantation for multiple myeloma
por: Vincent, L, et al.
Publicado: (2015)

Bone Marrow Microenvironment in Multiple Myeloma Progression
por: Manier, S., et al.
Publicado: (2012)

Extramedullary relapse of Immunoglobulin A-kappa myeloma manifesting as plasmacytoma of the pleura without bone marrow involvement and following autologous bone marrow transplant: a case report
por: Rezvani, Alireza, et al.
Publicado: (2023)

Risk of relapse of multiple myeloma following kidney transplantation
por: Shah, Sapna, et al.
Publicado: (2019)

Treating Multiple Myeloma in the Context of the Bone Marrow Microenvironment
por: Ho, Matthew, et al.
Publicado: (2022)

Colistin-Induced Acute Kidney Injury and the Effect on Survival in Patients with Multidrug-Resistant Gram-Negative Infections: Significance of Drug Doses Adjusted to Ideal Body Weight
por: Arrayasillapatorn, Nittha, et al.
Publicado: (2021)

Autologous bone marrow transplantation in patients relapsed one year after R-CHOP?
por: Pereira, Juliana
Publicado: (2012)

Predictive Value of Post-Transplant Bone Marrow Plasma Cell Percent in Multiple Myeloma Patients Undergone Autologous Transplantation
por: Hwang, In Hye, et al.
Publicado: (2011)

Transcriptomic profile induced in bone marrow mesenchymal stromal cells after interaction with multiple myeloma cells: implications in myeloma progression and myeloma bone disease
por: Garcia-Gomez, Antonio, et al.
Publicado: (2014)

Effect of thalidomide on bone marrow angiogenesis in multiple myeloma patients
por: Cury, Priscilla Cury de Camargo, et al.
Publicado: (2020)

Bone marrow niche in multiple myeloma and its precursor states
por: Sklavenitis-Pistofidis, Romanos, et al.
Publicado: (2019)

The non-peptide thrombopoietin receptor agonist eltrombopag stimulates megakaryopoiesis in bone marrow cells from patients with relapsed multiple myeloma
por: Jeong, Jee-Yeong, et al.
Publicado: (2015)

Interleukin-6 Interweaves the Bone Marrow Microenvironment, Bone Loss, and Multiple Myeloma
por: Harmer, Danielle, et al.
Publicado: (2019)

Pulmonary Lymphangitic Spread of Multiple Myeloma as Early Relapse after Autologous Stem Cell Transplantation
por: Thapa, Bicky, et al.
Publicado: (2021)

Pericardial relapse of multiple myeloma
por: Jamison, Lee S, et al.
Publicado: (2020)

Investigation of Gene Expressions of Myeloma Cells in the Bone Marrow of Multiple Myeloma Patients by Transcriptome Analysis
por: Sarıman, Melda, et al.
Publicado: (2019)

Bone Marrow Mesenchymal Stromal Cells in Multiple Myeloma: Their Role as Active Contributors to Myeloma Progression
por: Maiso, Patricia, et al.
Publicado: (2021)

Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical Results
por: Fazzi, Rita, et al.
Publicado: (2021)

In Situ Leukemia as Manifestation of Relapse After Allogeneic Transplantation of Bone Marrow of ALL B: A Case Report
por: Cordeiro de Macedo Pontes, Irline, et al.
Publicado: (2018)

Remitting–relapsing multiple sclerosis patient refractory to conventional treatments and bone marrow transplantation who responded to natalizumab
por: Mouzaki, Athanasia, et al.
Publicado: (2010)

Adverse Prognostic Impact of Bone Marrow Microvessel Density in Multiple Myeloma
por: Lee, Nuri, et al.
Publicado: (2015)

Micro-RNAs, New performers in multiple myeloma bone marrow microenvironment
por: Abdi, Jahangir, et al.
Publicado: (2014)

Metastatic prostate cancer with bone marrow infiltration mimicking multiple myeloma
por: Mathur, Pankaj, et al.
Publicado: (2017)

The Role of the Local Bone Marrow Renin-Angiotensin System in Multiple Myeloma
por: Saka, Bülent, et al.
Publicado: (2019)

Exosomes in the Pathogenesis and Treatment of Multiple Myeloma in the Context of the Bone Marrow Microenvironment
por: Chen, Tianzeng, et al.
Publicado: (2020)

Targeted Approaches to Inhibit Sialylation of Multiple Myeloma in the Bone Marrow Microenvironment
por: Natoni, Alessandro, et al.
Publicado: (2019)

Bone Marrow Stromal Cells-Induced Drug Resistance in Multiple Myeloma
por: Ria, Roberto, et al.
Publicado: (2020)

Bone Marrow Stroma-Induced Transcriptome and Regulome Signatures of Multiple Myeloma
por: Dziadowicz, Sebastian A., et al.
Publicado: (2022)

Assessment of Bone Marrow Biopsy and Cytogenetic Findings in Patients with Multiple Myeloma
por: Şeyhanlı, Ahmet, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hv1g1as6snj4jl1hcq0723pgr3